Loading live market data…

Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

$56.11 USD

-$3.2 (-5.4%)

Volume
2.08M
Average Volume
881.37K
Market Capitalization
$2.41B
P/E Ratio
-49.22
Dividend Yield
0.00%
Price Target
$68.00
Year High
$85.25
Year Low
$38.51
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.74

TARS Estimated and Actual Revenue by Quarter

TARS Estimated and Actual EPS by Quarter

TARS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 2 -188.68M -179.77M -184.16M -189.72M -180.76M -185.18M
2028-09-30 2 -172.38M -164.24M -168.25M -173.33M -165.15M -169.18M
2028-06-30 2 -166.93M -159.05M -162.93M -167.85M -159.93M -163.83M
2028-03-31 2 -150.67M -143.56M -147.06M -151.5M -144.35M -147.87M
2027-12-31 3 -146.92M -139.99M -143.4M -147.73M -140.76M -144.19M
2027-09-30 3 -135.07M -128.69M -131.83M -135.81M -129.4M -132.56M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 2 60.87M 64.82M 62.81M 652.58M 684.92M 668.5M
2028-09-30 2 51.08M 54.39M 52.71M 596.21M 625.75M 610.75M
2028-06-30 2 43M 45.79M 44.37M 577.35M 605.96M 591.44M
2028-03-31 2 30.37M 32.34M 31.34M 521.11M 546.93M 533.83M
2027-12-31 3 41.31M 43.99M 42.63M 508.16M 533.34M 520.56M
2027-09-30 3 29.5M 31.41M 30.44M 467.16M 490.3M 478.56M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 2 306.07M 321.24M 313.54M 2 1.41692 1.50887 1.4622
2028-09-30 2 279.63M 293.49M 286.45M 2 1.1891 1.26626 1.2271
2028-06-30 2 270.79M 284.2M 277.39M 2 1.00101 1.06597 1.033
2028-03-31 2 244.41M 256.52M 250.37M 2 0.70691 0.75278 0.7295
2027-12-31 3 238.33M 250.14M 244.15M 1 0.9616 1.024 0.99233
2027-09-30 3 219.1M 229.96M 224.45M 1 0.68673 0.73129 0.70867